BTG INTERNATIONAL INC

BTG INTERNATIONAL INC specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the production of potassium iodide tablets for federal health and emergency response programs. The company leverages precise formulation and cGMP-compliant manufacturing processes to deliver stable, high-purity oral solid dosage forms, particularly for radiological preparedness and thyroid blocking applications. Their technical capabilities include tablet compression, blending, quality control testing, and packaging under strict regulatory standards, ensuring consistent potency and bioavailability. A key differentiator is their proven ability to meet urgent federal timelines for life-saving pharmaceuticals, demonstrating agility in small-batch, high-integrity production cycles. The contractor maintains a consistent relationship with the Department of Health and Human Services and the Department of Veterans Affairs, supplying critical pharmaceuticals under Federal Supply Schedule and direct procurement mechanisms. For HHS, they deliver potassium iodide tablets for nuclear emergency stockpiles, while for the VA, they support broader pharmaceutical and hematology product lines under long-term supply agreements. These engagements reflect a trusted vendor status in the federal medical countermeasure supply chain. Their primary industry focus is pharmaceutical preparation manufacturing under NAICS 325412, where they serve niche public health and defense needs requiring precise dosing and regulatory adherence. They are positioned as a specialized manufacturer for government-mandated pharmaceuticals rather than commercial-scale drug production, filling a critical gap in the federal supply chain for non-proprietary, high-demand therapeutic agents. As a 2L entity based in Conshohocken, Pennsylvania, BTG INTERNATIONAL INC operates as a mid-tier manufacturer with no disclosed federal certifications. Their geographic footprint is centered in the Northeast, supporting federal agencies through reliable domestic production capacity and compliance with FDA and DEA regulatory frameworks.